vs
LXP Industrial Trust（LXP）与RHYTHM PHARMACEUTICALS, INC.（RYTM）财务数据对比。点击上方公司名可切换其他公司
LXP Industrial Trust的季度营收约是RHYTHM PHARMACEUTICALS, INC.的1.5倍（$86.7M vs $57.3M），LXP Industrial Trust净利率更高（33.2% vs -83.0%，领先116.1%），RHYTHM PHARMACEUTICALS, INC.同比增速更快（36.9% vs -14.0%），过去两年RHYTHM PHARMACEUTICALS, INC.的营收复合增速更高（48.5% vs 0.3%）
LXP工业信托是一家公开上市的房地产投资信托，专注于持有、运营和投资美国核心市场的优质工业地产，主要涵盖配送中心、物流设施及轻型工业物业，服务电商、第三方物流、先进制造等领域租户，为投资者创造长期稳定收益。
Rhythm Pharmaceuticals是一家专注于罕见病领域的生物制药企业，主要开发和商业化针对罕见遗传性肥胖症的靶向疗法，覆盖POMC缺陷、LEPR缺陷、巴德-毕德氏综合征等适应症，服务北美、欧洲地区缺少有效治疗方案的患者群体。
LXP vs RYTM — 直观对比
营收规模更大
LXP
是对方的1.5倍
$57.3M
营收增速更快
RYTM
高出50.9%
-14.0%
净利率更高
LXP
高出116.1%
-83.0%
两年增速更快
RYTM
近两年复合增速
0.3%
损益表 — Q4 FY2025 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $86.7M | $57.3M |
| 净利润 | $28.8M | $-47.5M |
| 毛利率 | 81.5% | 91.6% |
| 营业利润率 | 34.6% | -82.2% |
| 净利率 | 33.2% | -83.0% |
| 营收同比 | -14.0% | 36.9% |
| 净利润同比 | — | -9.6% |
| 每股收益（稀释后） | — | $-0.73 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收LXPRYTM
| Q4 25 | $86.7M | $57.3M | ||
| Q3 25 | $86.9M | $51.3M | ||
| Q2 25 | $87.7M | $48.5M | ||
| Q1 25 | $88.9M | $32.7M | ||
| Q4 24 | $100.9M | $41.8M | ||
| Q3 24 | $85.6M | $33.3M | ||
| Q2 24 | $85.8M | $29.1M | ||
| Q1 24 | $86.3M | $26.0M |
净利润LXPRYTM
| Q4 25 | $28.8M | $-47.5M | ||
| Q3 25 | $36.3M | $-52.9M | ||
| Q2 25 | $29.1M | $-46.6M | ||
| Q1 25 | $19.0M | $-49.5M | ||
| Q4 24 | — | $-43.3M | ||
| Q3 24 | $6.3M | $-43.6M | ||
| Q2 24 | $5.4M | $-32.3M | ||
| Q1 24 | $-269.0K | $-141.4M |
毛利率LXPRYTM
| Q4 25 | 81.5% | 91.6% | ||
| Q3 25 | 82.3% | 89.3% | ||
| Q2 25 | 81.9% | 88.6% | ||
| Q1 25 | 80.7% | 88.8% | ||
| Q4 24 | 85.3% | 90.9% | ||
| Q3 24 | 82.5% | 88.5% | ||
| Q2 24 | 82.0% | 89.9% | ||
| Q1 24 | 82.4% | 89.2% |
营业利润率LXPRYTM
| Q4 25 | 34.6% | -82.2% | ||
| Q3 25 | 50.4% | -102.6% | ||
| Q2 25 | 33.7% | -93.4% | ||
| Q1 25 | 21.8% | -143.7% | ||
| Q4 24 | — | -98.6% | ||
| Q3 24 | 7.9% | -132.0% | ||
| Q2 24 | 6.9% | -139.2% | ||
| Q1 24 | 1.0% | -538.7% |
净利率LXPRYTM
| Q4 25 | 33.2% | -83.0% | ||
| Q3 25 | 41.7% | -103.1% | ||
| Q2 25 | 33.2% | -96.1% | ||
| Q1 25 | 21.4% | -151.4% | ||
| Q4 24 | — | -103.6% | ||
| Q3 24 | 7.4% | -131.2% | ||
| Q2 24 | 6.3% | -110.9% | ||
| Q1 24 | -0.3% | -544.4% |
每股收益（稀释后）LXPRYTM
| Q4 25 | — | $-0.73 | ||
| Q3 25 | $0.12 | $-0.82 | ||
| Q2 25 | $0.09 | $-0.75 | ||
| Q1 25 | $0.06 | $-0.81 | ||
| Q4 24 | — | $-0.71 | ||
| Q3 24 | $0.02 | $-0.73 | ||
| Q2 24 | $0.01 | $-0.55 | ||
| Q1 24 | $-0.01 | $-2.35 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $170.4M | $388.9M |
| 总债务越低越好 | $1.4B | — |
| 股东权益账面价值 | $2.0B | $139.1M |
| 总资产 | $3.5B | $480.2M |
| 负债/权益比越低杠杆越低 | 0.66× | — |
8季度趋势，按日历期对齐
现金及短期投资LXPRYTM
| Q4 25 | $170.4M | $388.9M | ||
| Q3 25 | $229.7M | $416.1M | ||
| Q2 25 | $71.0M | $291.0M | ||
| Q1 25 | $70.9M | $314.5M | ||
| Q4 24 | $101.8M | $320.6M | ||
| Q3 24 | $55.0M | $298.4M | ||
| Q2 24 | $48.7M | $319.1M | ||
| Q1 24 | $293.8M | $201.2M |
总债务LXPRYTM
| Q4 25 | $1.4B | — | ||
| Q3 25 | $1.5B | — | ||
| Q2 25 | $1.5B | — | ||
| Q1 25 | $1.5B | — | ||
| Q4 24 | $1.6B | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
股东权益LXPRYTM
| Q4 25 | $2.0B | $139.1M | ||
| Q3 25 | $2.1B | $148.8M | ||
| Q2 25 | $2.1B | $-11.9M | ||
| Q1 25 | $2.1B | $18.9M | ||
| Q4 24 | $2.1B | $21.7M | ||
| Q3 24 | $2.1B | $11.2M | ||
| Q2 24 | $2.1B | $39.3M | ||
| Q1 24 | $2.2B | $61.6M |
总资产LXPRYTM
| Q4 25 | $3.5B | $480.2M | ||
| Q3 25 | $3.7B | $506.9M | ||
| Q2 25 | $3.7B | $372.7M | ||
| Q1 25 | $3.8B | $386.7M | ||
| Q4 24 | $3.8B | $392.3M | ||
| Q3 24 | $3.9B | $363.6M | ||
| Q2 24 | $3.9B | $381.8M | ||
| Q1 24 | $4.2B | $258.7M |
负债/权益比LXPRYTM
| Q4 25 | 0.66× | — | ||
| Q3 25 | 0.72× | — | ||
| Q2 25 | 0.72× | — | ||
| Q1 25 | 0.73× | — | ||
| Q4 24 | 0.75× | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $188.7M | $-25.4M |
| 自由现金流经营现金流 - 资本支出 | — | — |
| 自由现金流率自由现金流/营收 | — | — |
| 资本支出强度资本支出/营收 | — | — |
| 现金转化率经营现金流/净利润 | 6.56× | — |
| 过去12个月自由现金流最近4个季度 | — | — |
8季度趋势，按日历期对齐
经营现金流LXPRYTM
| Q4 25 | $188.7M | $-25.4M | ||
| Q3 25 | $63.5M | $-26.6M | ||
| Q2 25 | $44.3M | $-23.3M | ||
| Q1 25 | $39.0M | $-40.4M | ||
| Q4 24 | $211.2M | $-18.8M | ||
| Q3 24 | $64.6M | $-25.2M | ||
| Q2 24 | $38.5M | $-29.1M | ||
| Q1 24 | $38.9M | $-40.7M |
现金转化率LXPRYTM
| Q4 25 | 6.56× | — | ||
| Q3 25 | 1.75× | — | ||
| Q2 25 | 1.52× | — | ||
| Q1 25 | 2.05× | — | ||
| Q4 24 | — | — | ||
| Q3 24 | 10.18× | — | ||
| Q2 24 | 7.09× | — | ||
| Q1 24 | — | — |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
